ArticleBiomedicines2022

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation-A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients.

Michael Hultström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.